IDEAS home Printed from https://ideas.repec.org/p/pra/mprapa/17979.html
   My bibliography  Save this paper

Economic Insights and Deficits in European Biotechnology Patent Policy

Author

Listed:
  • Gilroy, Bernard Michael
  • Vollpert, Tobias

Abstract

The decisive statutory provision of the EU for patent protection of genetic engineering inventions is the so-called directive on biotechnological patents (DBP). Its objective is the encouragement of research and development in the genetic engineering sector. The following exposition shows that the DBP has two major flaws from the economist's point of view, under which particularly small and medium-sized enterprises, the driving force of this young line of business, suffer.

Suggested Citation

  • Gilroy, Bernard Michael & Vollpert, Tobias, 2002. "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper 17979, University Library of Munich, Germany.
  • Handle: RePEc:pra:mprapa:17979
    as

    Download full text from publisher

    File URL: https://mpra.ub.uni-muenchen.de/17979/1/MPRA_paper_17979.pdf
    File Function: original version
    Download Restriction: no

    Other versions of this item:

    References listed on IDEAS

    as
    1. Denicolo, Vincenzo, 1999. "The optimal life of a patent when the timing of innovation is stochastic," International Journal of Industrial Organization, Elsevier, vol. 17(6), pages 827-846, August.
    2. Paul Klemperer, 1990. "How Broad Should the Scope of Patent Protection Be?," RAND Journal of Economics, The RAND Corporation, pages 113-130.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Gilroy, Bernard Michael & Brandes, Wolfgang & Volpert, Tobias, 2003. "Economic Implications of Intellectual Property Rights for the Biotechnology Sector: A Comparative Analysis of the European-Japanese Situations," MPRA Paper 22200, University Library of Munich, Germany.

    More about this item

    Keywords

    Patent policy; biotechnology sector; Europe;

    JEL classification:

    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pra:mprapa:17979. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Joachim Winter). General contact details of provider: http://edirc.repec.org/data/vfmunde.html .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.